Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
33.60
-1.41 (-4.03%)
Jun 27, 2025, 4:00 PM - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $205.47 million as of June 27, 2025. Its market cap has increased by 1,417.15% in one year.
Market Cap
205.47M
Enterprise Value
150.92M
1-Year Change
1,417.15%
Ranking
Category
Stock Price
$33.60
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $205.47M, a decrease of -25.60%. That is a compound annual growth rate of -5.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.04B |
| Johnson & Johnson | 367.67B |
| AbbVie | 333.53B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 276.65B |
| Abbott Laboratories | 234.18B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |